Enhancing health outcomes and savings through value-based solutions
Patient engagement paired with cost-containment strategies drives better health outcomes and reduces the financial burden for plan sponsors.
Read MoreWhat’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?
The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.
Read MoreStudy: Progression of cardiodiabesity increases care utilization and costs
The Evernorth Research Institute’s latest cardiodiabesity report helps illustrate sites of care where preventive interventions can make the greatest financial impact.
Read MoreEvernorth Announces Industry-First Financial Guarantee For GLP-1 Spend
EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.
Read MoreHow Mohawk Industries built a culture of health and wellness – with access to care right at the workplace
Mohawk and Evernorth Workplace Care have developed a holistic, personalized strategy that prioritizes convenient access to care, right in the workplace.
Read MoreResearch: Sleep apnea drives average medical costs up 50% for patients with cardiodiabesity
Researchers have identified sleep apnea as a common comorbidity among patients with cardiodiabesity.
Read MoreWhat impact will the Inflation Reduction Act have on health plans?
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Read More